2509248

Buvat J

1989

Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective.

2509254

Walmer DK

1989

Ovarian hyperstimulation in polycystic ovary syndrome during therapy with leuprolide acetate.

2509303

Tanbo T

1989

Gonadotropin and ovarian steroid production in polycystic ovarian syndrome during suppression with a gonadotropin-releasing hormone agonist.

2509319

Sir T

1989

Clomiphene citrate and LH pulsatility in PCO syndrome.

2512039

Eden JA

1989

The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.

2512181

Dodson WC

1989

Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.

2512978

Traub AI

1989

Therapeutic focus. Metrodin.

2513132

Liao DL

1989

[Influence of artificial cycles induced by traditional Chinese medicine on the releasing and reserving gonadotropic hormone function of the pituitary gland in the female with secondary amenorrhea].

2513151

Franks S

1989

Polycystic ovary syndrome: a changing perspective.

2513236

Segos C

1989

Increased dopamine turnover in women with polycystic ovary syndrome.

2513454

Mauvais-Jarvis P

1989

Pathophysiology of polycystic ovary syndrome.

2513455

Salat-Baroux J

1989

[Treatment of ovarian polycystic syndrome in vitro. Physiopathogenetic considerations].

2513456

Jones GS

1989

Gonadotropin stimulation protocols in the Norfolk IVF program--1988.

2514053

Buckler HM

1989

GnRH agonist administration in polycystic ovary syndrome.

2516391

McFaul PB

1989

Premature luteinization and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome.

2516481

Don?t J

1989

[The hormonal profile in the polycystic ovary syndrome].

2516704

Prelevi? GM

1989

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.

2516706

Dale PO

1989

GnRH-agonist therapy in women with the polycystic ovarian syndrome: effects on ovarian volume and on gonadotropin and sex steroid levels.

2516707

Ferriani RA

1989

Dopamine might not be involved in the pathogenesis of polycystic ovary syndrome.

2520038

Tan TT

1989

Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.

2521223

Amice V

1989

Increase in H-Y antigen-positive lymphocytes in hirsute women: effects of cyproterone acetate and estradiol treatment.

2521402

Langebrekke A

1989

[Laser endoscopy in gynecology].

2521688

Barnes RB

1989

Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.

2521837

Huber J

1989

[Endoscopic laser incision of the polycystic ovary].

2522836

Scott MG

1989

Hormonal evaluation of female infertility and reproductive disorders.

2522898

Nappi C

1989

Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovarian disease.

2522899

Ashkenazi J

1989

IVF-ET in women with refractory polycystic ovarian disease.

2524175

Smetnik VP

1989

[Endogenous opioid peptides and the endocrine function of the reproductive system].

2524501

de Ziegler D

1989

Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.

2525452

Gualdi GF

1989

[Magnetic resonance in the evaluation of pathology of the uterus and ovary].

2526030

Cohen BM

1989

Laser laparoscopy for polycystic ovaries.

2527554

Eden JA

1989

The diagnosis of polycystic ovaries in subfertile women.

2527986

Kojima E

1989

Ovarian wedge resection with contact Nd:YAG laser irradiation used laparoscopically.

2527987

Yanagibori A

1989

Nd:YAG laser therapy for infertility with a contact-type probe.

2528448

Takakura K

1989

Aggravation of inappropriate luteinizing hormone secretion by bromocriptine in polycystic ovary syndrome with elevated serum dehydroepiandrosterone sulfate.

2528489

van der Weiden RM

1989

Endocrine effects of laparoscopic ovarian electrocautery in patients with polycystic ovarian disease, resistant to clomiphene citrate.

2528880

Sobbrio GA

1989

Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.

2529789

Dolian GG

1989

[Diagnostic criteria for polycystic ovary syndrome].

2529831

Freude G

1989

[Initial experiences and results with the GnRH agonist D-TRP 6 LHRH (decapeptyl-CR) in the treatment of polycystic ovary syndrome].

2530066

Yang LC

1989

[Laparoscopy in the diagnosis of polycystic ovarian syndrome].

2530117

Dabirashrafi H

1989

Complications of laparoscopic ovarian cauterization.

2530589

Elias AN

1989

Relationship between beta-endorphin/beta-lipotropin, hyperglycemia, and hyperinsulinemia in obese male Zucker rats.

2530821

V?tr M

1989

Hirsutism--a low dose spironolactone therapy.

2531535

Laatikainen TJ

1989

Response of plasma beta-endorphin and insulin to oral glucose tolerance test in non-obese women with polycystic ovaries.

2532082

Hague WM

1989

Steroid responses to ACTH in women with polycystic ovaries.

2532471

Matteri RK

1989

Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.

2532876

Peserico A

1989

Prevalence of polycystic ovaries in women with acne.

2532926

Bunker CB

1989

Most women with acne have polycystic ovaries.

2532984

Berga SL

1989

Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.

2533011

Keckstein J

1989

Laparoscopic treatment of polycystic ovarian syndrome.

2533526

Williams IA

1989

An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin.

2533620

Shaw RW

1989

Use of nafarelin to investigate the pathophysiology of the polycystic ovary syndrome.

2533668

Marchino GL

1989

[Endoscopic treatment of polycystic ovary syndrome. Preliminary data].

2542098

Pekonen F

1989

Decreased 34K insulin-like growth factor binding protein in polycystic ovarian disease.

2555033

Lucisano A

1989

[Partial deficiency in 21-hydroxylase in certain forms of hirsutism].

2557144

Carriere PD

1989

The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat.

2563704

Caruso A

1989

Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.

2566531

Giorlandino C

1989

Ovarian development of the female child and adolescent: I. Morphology.

2567714

McFaul PB

1989

Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment.

2576551

Chavis WM

1989

Psychosexual aspects of virilization syndrome.

2579886

Hughesdon PE

1985

Giant nodular ovaries with aberrant follicles.

2589107

Golland IM

1989

Lack of predictive value of HbA1 for impaired glucose tolerance in polycystic ovary syndrome.

2594623

Hopayian K

1989

Contraception and irregular menses.

2598362

Yu J

1989

[Experimental studies on the relation of the kidney and reproduction].

2603029

Makeev SA

1989

[Sclerocystic ovary syndrome associated with tumors of the adrenal medulla].

2608225

Goulding A

1989

Fasting urinary calcium/creatinine and hydroxyproline/creatinine values in young women with amenorrhoea and in matched eumenorrhoeic controls.

2611992

Lavoie R

1989

Determination of free testosterone fraction of human serum by gel bead dialysis.

2616412

Bryce GM

1989

The ovarian remnant syndrome presenting with acute urinary retention.

2621853

Furuhashi N

1989

[Clinical significance of serum estrone analysis in endocrine tests of the gonadal and placental system].

2624067

Falsetti L

1989

Polycystic ovary syndrome: long-term evolution.

2626048

Bonney RC

1989

17 beta-Hydroxysteroid oxidoreductase activity in the endometrium of normal women and patients with pelvic pain and polycystic ovaries.

2632509

Khandekar S

1989

Circulating androgens in hirsutism.

2642810

Erickson GF

1989

Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplasia.

2642919

Dunaif A

1989

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.

2655482

Serov VN

1989

[Neuroendocrine syndrome with disorders of the reproductive functions: their clinical problems and pathogenesis].

2655483

Pamfamirov IuK

1989

[Current methods of the treatment of patients with sclerocystic ovary syndrome].

2658471

Rossmanith WG

1989

Endocrine dynamics during pulsatile GnRH administration in patients with hypothalamic amenorrhea and polycystic ovarian disease.

2658472

Braat DD

1989

Pregnancy outcome in luteinizing hormone-releasing hormone induced cycles: a multicentre study.

2660088

Bailey-Pridham DD

1989

Hirsutism in the adolescent female.

2660773

Rojanasakul A

1989

Clinical presentation, hormonal profiles and ultrasonic ovarian morphology in women with suspected polycystic ovarian disease.

2661643

Pampfer S

1989

[Clinical value of inhibin in women].

2665539

Alieva EA

1989

[Pathophysiology of the polycystic ovary syndrome].

2667634

Hague WM

1989

45 X Turner's syndrome in association with polycystic ovaries. Case report.

2668713

Randazzo C

1989

[Inhibition of pancreatic beta-cell secretion during glucose clamp in patients with polycystic ovary syndrome].

2670645

Dunaif A

1989

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

2672267

Buvat J

1989

[When and why should hyperandrogenism be searched for in women?].

2672269

Buvat J

1989

[Treatment of the gynecologic consequences of hyperandrogenism].

2675777

Prelevi? GM

1989

The effect of residual beta cell activity on menstruation and the reproductive hormone profile of insulin-dependent diabetics.

2679448

Urdl W

1989

[Growth factors, carbohydrate and lipid metabolism in females with polycystic ovary syndrome].

2680614

Surrey ES

1989

Effects of gonadotropin-releasing hormone (GnRH) agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease.

2684835

Mahabeer S

1989

Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.

2686354

Schivardi MR

1989

Ovulation induction with intravenous gonadotropin-releasing hormone.

2686438

Nestler JE

1989

The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome.

2688996

Conway GS

1989

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients.

2689746

Wang SC

1989

Polycystic ovary syndrome.

2689786

Bringer J

1989

[Pulsatile administration of LH-RH: diagnostic and therapeutic applications].

2689843

Kazer R

1989

The etiology of polycystic ovary syndrome (PCO).

2692374

Coiro V

1989

Arginine vasopressin secretion in non-obese women with polycystic ovary syndrome.

2693519

Boukhris R

1989

[Sex hormones and the skin].

2696005

Herrera Pombo JL

1989

[Polycystic ovary: old concepts, new perspectives].